Premium
P3‐251: SERUM NEUROFILAMENT LIGHT CHAIN LEVELS ARE ASSOCIATED WITH CSF NEUROFILAMENT LIGHT CHAIN, COGNITIVE STATUS, AND DISEASE PROGRESSION IN AUTOSOMAL DOMINANT AD
Author(s) -
Preische Oliver,
Schultz Stephanie A.,
Apel Anja,
Kuhle Jens,
Gordon Brian A.,
Wang Guoqiao,
McDade Eric,
Bateman Randall J.,
Morris John C.,
Benzinger Tammie L.S.,
Jucker Mathias
Publication year - 2018
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2018.06.1611
Subject(s) - asymptomatic , dementia , medicine , cohort , disease , oncology , lumbar puncture , psychology , cerebrospinal fluid , pathology
BMI: body mass index; FGF21: fibroblast growth factor 21; HbA1C: Glycated hemoglobin A1C; HDL-C: high density lipoprotein cholesterol HOMA index: Homeostasis Model Assessment index; LDL-C: low density lipoprotein cholesterol; MoCA: Montreal cognitive assessment; SBP: systolic blood pressure. Oliver Preische, Stephanie A. Schultz, Anja Apel, Jens Kuhle, Brian A. Gordon, Guoqiao Wang, Eric McDade, Randall J. Bateman, John C. Morris, Tammie L. S. Benzinger, Mathias Jucker, Department of Psychiatry and Psychotherapy, University of Tuebingen, Tuebingen, Germany; Washington University in St. Louis School of Medicine, St. Louis, MO, USA; German Center for Neurodegenerative Diseases, Tuebingen, Germany; Hertie Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany; University Hospital Basel, Basel, Switzerland; Knight Alzheimer’s Disease Research Center, St. Louis, MO, USA; Washington University School of Medicine, St. Louis, MO, USA; Washington University School of Medicine, Saint Louis, MO, USA. Contact e-mail: saschultz@wustl.edu